Company research
BioKey (Cayman), Inc.
CIK 2108359
Filing activity
11 filings on record · 10-Q, 8-K/A, 8-K, NT 10-Q, SEC STAFF ACTION, 10-12G/A.
Recent filings
10-Q filing
Financial Statements and Exhibits
Items 9.01
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
10-Q filing
NT 10-Q filing
Show 5 more recent filings
Changes in Registrant's Certifying Accountant
Items 4.01, 9.01
Changes in Registrant's Certifying Accountant
Items 4.01, 9.01
Other Events
Items 8.01
SEC STAFF ACTION filing
10-12G/A filing
Filing attachments
ea030361701ex99-1.htm · 8-K/A · 2026-08-27
EX-99.1 2 ea030361701ex99-1.htm INFORMATION STATEMENT OF BIOKEY (CAYMAN), INC., DATED AUGUST 27, 2026 (FILED HEREWITH) Exhibit 99.1 INFORMATION STATEMENT BioKey (Cayman), Inc. Ordinary Shares (par value $0.0001 per share) This information statement has been prepared in connection with the spin-off by ABVC BioPharma, Inc. (“ ABVC ”) of its wholly owned subsidiary, BioKey (Cayman), Inc. (the “ Company,” “ SpinCo,” or “ BioKey Cayman ”). To effect the spin-off, ABVC distributed that number…
Read attachment ↗ea030290601ex99-1.htm · 8-K · 2026-08-27
EX-99.1 7 ea030290601ex99-1.htm INFORMATION STATEMENT OF BIOKEY (CAYMAN), INC., DATED AUGUST [ ], 2026 Exhibit 99.1 INFORMATION STATEMENT BioKey (Cayman), Inc. Ordinary Shares (par value $0.0001 per share) This information statement has been prepared in connection with the spin-off by ABVC BioPharma, Inc. (“ ABVC ”) of its wholly owned subsidiary, BioKey (Cayman), Inc. (the “ Company,” “ SpinCo,” or “ BioKey Cayman ”). To effect the spin-off, ABVC distributed that number of the Company’…
Read attachment ↗ea029422201ex99-1.htm · 10-12G/A · 2026-06-22
Exhibit 99.1 Information contained herein is subject to completion or amendment. A Registration Statement on Form 10 relating to these securities has been filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended. Preliminary and Subject to Completion, Dated June 22, 2026 INFORMATION STATEMENT BioKey (Cayman), Inc. Ordinary Shares (par value $0.0001 per share) This information statement has been prepared in connection with the spin-o…
Read attachment ↗ea029154601ex99-1.htm · 10-12G · 2026-05-28
Exhibit 99.1 Information contained herein is subject to completion or amendment. A Registration Statement on Form 10 relating to these securities has been filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended. Preliminary and Subject to Completion, Dated May 27, 2026 INFORMATION STATEMENT BioKey (Cayman), Inc. Ordinary Shares (par value $0.0001 per share) We are sending you this information statement in connection with the spin-o…
Read attachment ↗